Incidence and Contributing Anthropometric Factors of Difficult Airway in Pediatric Surgical Patients
Launched by UNIVERSITY CHILDRENS HOSPITAL BELGRADE · Aug 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to predict and assess difficult airway situations in young children undergoing elective surgery. The researchers want to find out which physical factors, like the shape of a child's face and neck, can help identify if a child might have trouble with mask ventilation, laryngoscopy (looking at the throat), or intubation (inserting a breathing tube). By doing this, they hope to create a new scoring system that can better predict these challenges.
Eligible participants are children aged from one month to 14 years who are scheduled for elective surgery that requires general anesthesia. Before surgery, the child's airway will be evaluated through some simple measurements. On the day of the surgery, after the child is given anesthesia, the medical team will check how easy or difficult it is to manage the airway using standard scoring methods. This study is important as it could improve safety and care for young patients during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients from one month to 14 years old scheduled for elective surgery in general endotracheal anesthesia.
- Exclusion Criteria:
- • Congenital syndromes which include difficult airway (Pierre Robin, Goldenhar syndrome, Treacher Collins syn, Down syn, Edwards, Arthrogryposis, Apart syn etc.), craniofacial dysmorphia, ENT, maxillofacial and cardiac surgery patients, patients with resent respiratory infections
About University Childrens Hospital Belgrade
University Children’s Hospital Belgrade is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital focuses on improving treatment protocols and therapeutic outcomes for pediatric patients. With a commitment to evidence-based medicine, the institution collaborates with multidisciplinary teams of healthcare professionals and researchers to conduct rigorous studies that contribute to the broader scientific community. Its state-of-the-art facilities and dedication to ethical research practices ensure the highest standards of safety and efficacy in all clinical trials undertaken.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belgrade, , Serbia
Patients applied
Trial Officials
Ivana Petrov, MD
Principal Investigator
University children hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported